DINAMIQS inaugurates new cGMP viral vector manufacturing facility in Switzerland
The new site enables end-to-end production of viral vector gene therapies
The new site enables end-to-end production of viral vector gene therapies
Prolia is a prescription medicine used to treat osteoporosis in women
Conducted entirely in Europe across forty sites in five countries, this rigorous study met all clinical endpoints
The inspection concluded with zero form 483 observations
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
Encouraging early detection and breaking the silence around men’s health
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Subscribe To Our Newsletter & Stay Updated